Disparities in the Use of Sentinel Lymph Node Dissection for Early Stage Breast Cancer

Clinical trials have long established the long-term safety of omitting axillary lymph node dissection (ALND) after sentinel lymph node dissection (SLND) in patients with clinically node-negative early stage breast cancer. The variations in utilization of SLND and ALND in this patient population, however, are currently unknown.Adult female patients (40 years and older) within the National Cancer Database diagnosed with breast cancer between...